Menu
GeneBe

rs1349476281

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1_StrongPM2PP3_StrongPP5_Very_Strong

The NM_173660.5(DOK7):c.331+1G>T variant causes a splice donor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000356 in 1,405,646 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: not found (cov: 34)
Exomes 𝑓: 0.0000036 ( 0 hom. )

Consequence

DOK7
NM_173660.5 splice_donor

Scores

4
2
1
Splicing: ADA: 1.000
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:8

Conservation

PhyloP100: 8.97
Variant links:
Genes affected
DOK7 (HGNC:26594): (docking protein 7) The protein encoded by this gene is essential for neuromuscular synaptogenesis. The protein functions in aneural activation of muscle-specific receptor kinase, which is required for postsynaptic differentiation, and in the subsequent clustering of the acetylcholine receptor in myotubes. This protein can also induce autophosphorylation of muscle-specific receptor kinase. Mutations in this gene are a cause of familial limb-girdle myasthenia autosomal recessive, which is also known as congenital myasthenic syndrome type 1B. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Splicing variant, NOT destroyed by nmd, known LOF gene, truncates exone, which is 0.15181518 fraction of the gene. Cryptic splice site detected, with MaxEntScore 6.5, offset of 43, new splice context is: cagGTgtgc. Cryptic site results in frameshift change. If cryptic site found is not functional and variant results in exon loss, it results in inframe change.
PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF, max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
PP5
Variant 4-3473637-G-T is Pathogenic according to our data. Variant chr4-3473637-G-T is described in ClinVar as [Pathogenic]. Clinvar id is 449547.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-3473637-G-T is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
DOK7NM_173660.5 linkuse as main transcriptc.331+1G>T splice_donor_variant ENST00000340083.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
DOK7ENST00000340083.6 linkuse as main transcriptc.331+1G>T splice_donor_variant 1 NM_173660.5 P1Q18PE1-1

Frequencies

GnomAD3 genomes
Cov.:
34
GnomAD3 exomes
AF:
0.0000110
AC:
2
AN:
181712
Hom.:
0
AF XY:
0.0000101
AC XY:
1
AN XY:
98986
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000263
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000356
AC:
5
AN:
1405646
Hom.:
0
Cov.:
33
AF XY:
0.00000289
AC XY:
2
AN XY:
691962
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000122
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000371
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
34

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fetal akinesia deformation sequence 3 Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingBaylor GeneticsSep 12, 2023- -
Pathogenic, no assertion criteria providedliterature onlyOMIMMay 01, 2009- -
not provided Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingGeneDxDec 02, 2022Reported in a patient with congenital myasthenia who also harbored the common c.1124_1127dupTGCC variant (Selcen et al., 2008); Canonical splice site variant expected to result in aberrant splicing; Published functional studies demonstrate a damaging effect (Selcen et al., 2008); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 22482962, 18626973, 19261599) -
Pathogenic, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoAug 31, 2017- -
Congenital myasthenic syndrome 10 Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMMay 01, 2009- -
Fetal akinesia deformation sequence 1;C1850792:Congenital myasthenic syndrome 10 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingInvitaeMar 17, 2023This sequence change affects a donor splice site in intron 3 of the DOK7 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in DOK7 are known to be pathogenic (PMID: 16794080, 16917026, 18626973, 19261599). For these reasons, this variant has been classified as Pathogenic. Studies have shown that disruption of this splice site is associated with altered splicing resulting in multiple RNA products (PMID: 18626973). Experimental studies have shown that disruption of this splice site affects DOK7 function (PMID: 18626973). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 449547). Disruption of this splice site has been observed in individual(s) with DOK7-related conditions (PMID: 18626973, 19261599). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. -
Congenital myasthenic syndrome Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpNov 13, 2023Variant summary: DOK7 c.331+1G>T is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to exon skipping. At least one publication reports experimental evidence that this variant affects mRNA splicing by skipping exon 3 and the resultant in-frame muatant DOK7 failed to phosphorylate MuSK in HEK cells (Selcen_2008). The variant allele was found at a frequency of 1.1e-05 in 181712 control chromosomes. c.331+1G>T has been reported in the literature in multiple individuals affected with lethal Fetal akinesia deformation sequence syndrome or Myasthenic Syndrome (examples, Vogt_2009, Selcen_2008). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 18626973, 19261599). Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Both submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
DOK7-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesJul 20, 2023The DOK7 c.331+1G>T variant is predicted to disrupt the GT donor site and interfere with normal splicing. This variant has been reported in patients with autosomal recessive congenital myasthenic syndrome (Selcen et al. 2008. PubMed ID: 18626973) and fetal akinesia deformation sequence (Vogt et al. 2009. PubMed ID: 19261599). This variant is reported in 0.0026% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/4-3475364-G-T). In summary, the c.331+1G>T variant is categorized as pathogenic for recessive DOK7-related disorders. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.60
D
BayesDel_noAF
Uncertain
-0.080
Cadd
Pathogenic
35
Dann
Uncertain
0.99
Eigen
Pathogenic
0.92
Eigen_PC
Pathogenic
0.67
FATHMM_MKL
Pathogenic
0.98
D
MutationTaster
Benign
1.0
D;D;D
GERP RS
3.7

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.89
SpliceAI score (max)
1.0
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.84
Position offset: -2
DS_DL_spliceai
1.0
Position offset: -1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1349476281; hg19: chr4-3475364; API